ArticleCancer science2014

Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors.

Hideki Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.